|
|
| |
|
* May 2000 Foundation of Medy-Tox, Inc.
* Jun 2000 Certified as EVC by KSMBA
* Jul 2001 Establishment of Microbial Toxin Research Institute
* Sep 2001 Strategic Alliance with Pacific Pharm Co. (a pharmaceutical subsidiary of the largest cosmetics company, Amorae Pacific Co.) of exclusive sales and distribution in Korea
for botulinum toxin type A injectables
* Aug 2002 Approval of "Protocol of clinical trial for botulinum toxin type A inj." by the KFDA
* Dec 2002 Completion of construction of the Korean Good Manufacturing Practice-compliant plant in Ochang, Korea
* Mar 2004 Completion of Phase III clinical trial of Botulinum toxin product
The first Korean bio-venture that finished Ph. III under the most recent "Regulations and Guidelines of Approval and Evaluation of Biologics " enforced by the Korean FDA in 2003
|
 회원 가입일 |
2004/11/11 (년/월/일) |
| 역할 구분 |
판매상 |
| 사업형태 |
제조업체 |
| 설립년도 |
2000 |
| 총 종업원수 |
51 - 100 |
| 연간매출 |
USD 2,000,001 - 5,000,000 |
|
| [ 연락처 정보 ] |
| 회사명 |
Medy-Tox Inc. |
| 주소 |
서울특별시 서초구 서초4동 1694-10번지 10층
(우:363-883) 한국 |
| 전화번호 |
82 - 2 - 34718319 |
| 팩스번호 |
82 - 2 - 6008-5078 |
| 홈페이지 |
www.medytox.com |
| 담당자 |
I.Y.Chang / Senior Manager |
|
|
|
| |
 |
Copyright(c) Medy-Tox Inc. All Rights Reserved.
Tel : 02-3471-8319 Fax : 02-6008-5078
|
|
|
|
|
